{"ticker": {"uuid": "99630101-fe74-424e-96f0-ddef270f3294", "symbol": "BFRI", "name": "Biofrontera Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Liquidity Sweep", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWUtScWNPTWxLZE9zUnV5dS1US2g2QkhqMDVJb2ZuY1NBLVMwNDRFVy1ZMHZhV1JuUHFXeE9fRWZGaW1hVURhMHJVeDlJX1U1V3pURDdWODJ1TTBQUUJnWF9RcFNsa21XakhzV2E2cUkyS3o3SDh6RUxyN0F4WjV1VXBRUVFtaEVabjNyU29Oa1NsRnVaMmw5MzdWdVpHYjBqQTFLbWxteWZIQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-11T14:40:08+00:00", "published_display": "11 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Hagopian Line", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPRGlER1Y3cGZ2VmVnNGJjQzdodUloY0Y3YzA4RkQ4dGRJY0hHcHhheHlfNC1MeW4xWFRuUE8wejkydWVkZTQtZXdWcFFLSkNiSTNqSTk0QkQzeWpJU3YxUHJ4VEJJS0lFRldSeGVKWlY0NU9CbGFLY2N3RjAtUEVKUDZOWjRTUjR0Nk5HZWlVWU5sUm51OVNCNFZNcmtmc0JkSkhnbzhNV1pKR3NXRnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-11T14:30:21+00:00", "published_display": "11 Jul 2026 14:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article focuses on the enterprise value to EBIT forward of Biofrontera Inc., traded on NASDAQ under the ticker BFRI. It is primarily a data page from TradingView, indicating financial metrics for the pharmaceutical company. The content provided is minimal, serving mainly as ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T10:40:04", "published_display": "11 Jul 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frontier tech research, news & data", "summary": "The article provides a detailed growth snapshot of Biofrontera Inc. (BFRI), covering its revenue, net income, and EPS growth rates year-over-year. It presents both annual and quarterly growth data from FY2019 to Q1 FY26, highlighting the company's financial performance trends. Th", "url": "https://mlq.ai/companies/biofrontera-inc/growth/", "source_name": "MLQ.ai", "published_at": "2026-07-10T02:10:50", "published_display": "10 Jul 2026 02:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) AGM 2026 Summary", "summary": "Biofrontera (BFRI) held its 2026 Annual General Meeting, where directors and key executives participated remotely. The agenda included proposals for electing two Class II directors, amending the 2021 Omnibus Incentive Plan, and ratifying the independent auditor. The meeting summa", "url": "https://quartr.com/events/biofrontera-inc-bfri-agm-2026_F9UlMgni", "source_name": "Quartr", "published_at": "2026-07-08T12:10:47", "published_display": "08 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article displays information regarding Biofrontera Inc. (NASDAQ: BFRI)'s enterprise value to forward EBITDA. The information is presented within a TradingView interface, which provides financial data and tools for market analysis. The content is primarily a data placeholder ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T07:10:36", "published_display": "08 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Q4 2025 earnings summary", "summary": "Biofrontera (BFRI) reported record annual revenues of $41.7 million in 2025, a 12% increase year-over-year, with Q4 revenues reaching $17.1 million. The company achieved profitability in Q4 with a net income of $5.6 million and adjusted EBITDA of $4.9 million, driven by an asset ", "url": "https://quartr.com/events/biofrontera-inc-bfri-q4-2025_F9UlTSmi", "source_name": "Quartr", "published_at": "2026-07-08T06:11:12", "published_display": "08 Jul 2026 06:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Proxy filing Summary", "summary": "Biofrontera (BFRI) has released a summary of its proxy filing for the 2026 Annual Meeting scheduled for June 11, 2026. Key proposals include the election of two Class II directors, an increase in authorized shares for the 2021 Omnibus Incentive Plan, and the ratification of CBIZ ", "url": "https://quartr.com/events/biofrontera-inc-bfri-proxy-filing_F9UlMGEe", "source_name": "Quartr", "published_at": "2026-07-08T03:11:12", "published_display": "08 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-earnings forward metric. It appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analysis or numerical values fo", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T09:09:44", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI SEC Filings - Biofrontera Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Biofrontera Inc. (BFRI) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details recent filings from September 2025, highlighting insider beneficial ownership, convertible preferred stock conversions, an", "url": "https://www.stocktitan.net/sec-filings/BFRI/page-4.html", "source_name": "Stock Titan", "published_at": "2026-07-05T00:11:40", "published_display": "05 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI - Biofrontera Inc Options", "summary": "This article provides a detailed financial overview of Biofrontera Inc. (BFRI), including its stock performance, valuation metrics, earnings data, and insider/institutional ownership. It highlights the company's recent stock price of $1.16, a significant percentage change, and ke", "url": "https://finviz.com/stock?t=BFRI&p=d&ty=oc&b=1", "source_name": "Finviz", "published_at": "2026-07-04T11:40:35", "published_display": "04 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of Biofrontera Inc.'s financial disclosures and SEC filings, including earnings reports, quarterly and annual reports, and investor conference summaries dating back to 2021. It details key financial metrics, clinical pipeline progress, a", "url": "https://www.tradingview.com/symbols/BOATS-BFRIW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T07:40:07", "published_display": "02 Jul 2026 07:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-sales forward ratio. The content, sourced from TradingView, indicates that the market was closed at the time of publication and no trades were recorded. It offers an overvie", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T08:09:51", "published_display": "30 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides a brief financial overview of Biofrontera Inc. (NASDAQ: BFRI), focusing on its price to book forward metric. It indicates that the market was closed at the time of publication and no trades were made. The content is primarily a financial data point without f", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T00:42:46", "published_display": "30 Jun 2026 00:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Biofrontera, Inc. \u2013 MUN:AI10", "summary": "The article title indicates a focus on the enterprise value to revenue forward ratio for Biofrontera, Inc. (MUN:AI10). The content found only contains this title and navigation information. No financial data or analysis is presented within the provided text.", "url": "https://www.tradingview.com/symbols/MUN-AI10/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T15:40:22", "published_display": "29 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A3EFRZ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Biofrontera, Inc. (A3EFRZ), including a 1-year price target of 5.11 EUR based on two analyst ratings. It also details recent financial performance, such as last quarter's earnings per share and revenue, and upcoming earnings report dates. The ", "url": "https://www.tradingview.com/symbols/LSX-A3EFRZ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T07:41:15", "published_display": "27 Jun 2026 07:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI10 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Biofrontera, Inc. (AI10) stock, based on analyst opinions, including maximum and minimum price estimates. It also details the company's financial performance, such as recent earnings and revenue, historical stock prices, and i", "url": "https://www.tradingview.com/symbols/MUN-AI10/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T02:10:20", "published_display": "27 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera, Inc. Actuals & Estimates (NASDAQ:BFRI)", "summary": "This article provides an overview of Biofrontera Inc. (NASDAQ: BFRI) stock, including its current price, historical performance, analyst forecasts, and financial data. It covers frequently asked questions regarding its stock ticker, price changes, market capitalization, earnings ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T10:09:35", "published_display": "26 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Biofrontera Inc. (BFRI) stock, incorporating analyst ratings, historical performance, and financial data. It addresses frequently asked questions about the stock's current price, volatility, market capitalization, earnings, an", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:42:46", "published_display": "26 Jun 2026 08:42", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Biofrontera Inc. \u2013 NASDAQ:BFRIW", "summary": "The article focuses on the \"Price to book forward\" financial metric for Biofrontera Inc. (NASDAQ: BFRIW). It appears to be a stub or a data point from a financial platform like TradingView, showing the value and change of this specific metric for the company. The content itself p", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRIW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T04:41:50", "published_display": "26 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Biofrontera Inc (BFRI) has a weak financial status but high operating efficiency, with a current financial score of 7.82, ranking 98 out of 157 in the Pharmaceuticals industry. The company recently reported a 17.42% year-over-year increase in quarterly revenue to $10.08M and a 13", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T18:40:20", "published_display": "23 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Shows Modest Bounce Near Key Support Level - Entry Point Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRW5TOTlaTVVYeGRaR2NwazgybzlUdGVkdk4xdjc1QW1NNjdlQVJBVW1IUmdXRjZYOWZaWFB4UTlsMzRJa2xJZndSUVhTSGJmVjkyNTMxcnNGaFNSdlVFeFlYTGpDS1NSeHVlRFZxWjNPdW00MG8xdlZ1b1NacUI0VW5OdDNycVpPWnM3NndWUTEwZG9GeEtMRWJUc2tBT2QyWmpVZ2lhOXdEY3h1SDI4?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc.'s (NASDAQ:BFRI) Path To Profitability", "summary": "Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company, is projected by analysts to reach profitability in 2027, with an anticipated breakeven point just over a year from the article's publication. This forecast relies on an optimistic annual growth rate of 63%. The company,", "url": "https://www.sahmcapital.com/news/content/biofrontera-incs-nasdaqbfri-path-to-profitability-2026-06-20", "source_name": "Sahm", "published_at": "2026-06-20T17:11:42", "published_display": "20 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Institutional Confidence", "summary": "This article from TradingKey provides an overview of Biofrontera Inc's (BFRI) institutional confidence score and shareholder activity as of June 18, 2026. It lists key institutional shareholders, the number of shares they hold, and the percentage change in their holdings. The com", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T04:10:40", "published_display": "19 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRIW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "The article provides a detailed breakdown of Biofrontera Inc's (BFRIW) shareholder structure, including categories of shareholders and institutional holdings over several recent quarters. It lists major institutional investors and their changes in shareholding, offering insights ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfriw/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T07:46:52", "published_display": "18 Jun 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Valuation: PE, PB & Fair Value Analysis", "summary": "Biofrontera Inc (BFRI) currently has a valuation score of 9.06, placing it 54th out of 157 in the Pharmaceuticals industry. Its P/E ratio stands at -1.01, which is significantly below its recent high but above its recent low. The company has not yet disclosed relevant data for P/", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T07:39:46", "published_display": "18 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "The article provides a historical overview of Biofrontera Inc's (BFRI) dividend distributions and stock split events. It notes that the company has not distributed any dividends in the past five years. However, it details multiple 20-for-1 merger-related stock splits that occurre", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:46", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Biofrontera Inc (BFRI), listing major shareholders and their proportions, including Rosalind Advisors, Inc. and AIGH Capital Management, LLC. It also breaks down shareholder types such as hedge funds and individual investors. Addi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:00", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Biofrontera Inc. (BFRI), detailing its segment and regional revenue contributions. However, it notes that relevant data for fiscal years 2021-2025 has not yet been disclosed by the company. The only specific financial detail provided ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:00", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (NASDAQ: BFRI) OKs directors, bigger incentive plan and auditor", "summary": "Biofrontera Inc. (BFRI) held its Annual Meeting of Stockholders on June 11, 2026, where shareholders approved several key proposals. They elected Beth J. Hoffman and Kevin D. Weber as Class II directors, significantly increased the authorized shares for the 2021 Omnibus Incentive", "url": "https://www.stocktitan.net/sec-filings/BFRI/8-k-biofrontera-inc-reports-material-event-751fbb62d041.html", "source_name": "Stock Titan", "published_at": "2026-06-17T19:39:00", "published_display": "17 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRIW) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Biofrontera Inc (BFRIW), including its stock price, market capitalization, and P/E TTM. It lists various institutional shareholders and their recent activity, such as shares held and changes in holdings. The data in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfriw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T08:11:34", "published_display": "17 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/e5890ce7-945e-34fe-a70a-c76ac3ac8384/biofrontera-%28bfri%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T17:16:02+00:00", "published_display": "02 Jun 2026 17:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Edges Higher: A Small-Cap Biotech Finds Temporary Footing - Low Volume Node", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOYWxiT0Y3a1BvM2tjaE1hcHdrLW1RLXFfTzZ6VzlLVWZONjU5cVQ4bGZYcXV2VGs1X01VMzlIQ2ZSSFpXT284Yk5sam1NOFllZjVXM3E5YWNVUEFWczVVLUFnU1owVHNwZzh4RE1wM0dXTzdFM3pSb0RnWkFneG5CZzNqVF80aXhYQ0NuWmtjbGxaNXBqX0VhMVZZbXhENlZMRGZrcklJMFdjYzAyTEk4dDRCZnVhano3RTUydmJHNjk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-participate-lytham-partners-131500277.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T13:15:00+00:00", "published_display": "21 May 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-bfri-q1-2026-230428053.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T23:04:28+00:00", "published_display": "14 May 2026 23:04", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-reports-first-quarter-113000573.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T11:30:00+00:00", "published_display": "14 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSXdpZV94UXMtWFp1alp5WVA0eXdEMklsdHFZdWNiNGVLUzJIZy1XNE9YS2ZHUG1obFZxd2IxaGZfQWEwXy1NSWlPREZmeXdYQlF4R0hGT3I1SlFacjhmdEU5c3k2dnc2S1ZBazhSc3F5ZHFkSzU0dlBRVHU4NENHWGlMb2dZTDhoR2tZajJ3Z05rNzdPSHNxNUM0elo?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BIOFRONTERA ($BFRI) Releases Q1 2026 Earnings | BFRI Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQSEJBSVVIZFpOOEV6MXJESm5EbTUyTkVZVWQxZFpfak1OSE5VMzA2bnRaaE9MQmsxbEtsTjZRSzRxMGRzTGZ5UkNzU0V5YnhiOG1Ub3NDd0d3LUtlX3BCWG5VUkpXNk9vN2Z1bVp1WU9lc3Y4cEZVdHdXSkR4OXpCckhhR1QxMXdPRDlKWg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Launches Second Annual \u201cHats On\u201d Campaign to Raise Awareness of Actinic Keratosis", "summary": "", "url": "https://finance.yahoo.com/news/biofrontera-launches-second-annual-hats-130000565.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T13:00:00+00:00", "published_display": "13 May 2026 13:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-report-first-quarter-200000977.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T20:00:00+00:00", "published_display": "08 May 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRzVzUEwxMm1RTy1oNmhaWGF2c3ZhMTM5dG8yOUZ6OGhONFlmY2l4SUpXTkhrblVHNi0tODRjTGdqRWtwcF9fU3ZLTTY2X0tVTm0wclpwZ2VubU1laGZoUlpoaFJDZTI5andGQ0dWNUtmZGZ6VU05OGZ0WjlmWnZXOExQcVBvd2ZrZTdtRVkwSk01V21VOHVzUzRVQXB1UWE0dDl1NXlQT2pMX0dJUVhIUWoxdUlzTHp6clBidXcyWUQxUEJZSzZwTUNjazY4bTAtMFIwVFdkYzZCd0QzNlHSAeMBQVVfeXFMT2JUQTloc1p1U0FJVm95RjdibTktNmhsR3FOTFducnJxUkd4WUtWMEM5RjBNWHhYakNpVzk5a1B4aXJVUzBBWHQyZ1l1VGdkUW5ueDlfVzEydWxnRUZ2NmJmVmFOY0RCUmphZ28xRzUwSmxrRldHZU5MNjlDWFVkdTA0QktxdExlWWgwd0UtZFppc0xCVXFaYjRPeldvVk1OV0pFTVFjODVaMmpMbFpZdGRaUndFMHQtRHZSYmZqdWJRYUlLcXQxMXdNQWdwaUJzUXhXNzN6TTZVWnh2ZXkyejBraFU?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVmR0bmpFcjZtWWY5WG8tS2dUa3JxTzZuZXVQMWJUeUlDTDAwRWNibm1KQjd4aWMzbGxjVml1OFNXek1KenQ0eVZ4TkxqUXE5UkJHVnhnLTY2Y3gxeWR4UlZBQWhmMmo3czBkdmpaS0lYbEQ5UmY0aS11cjBQRWdWS3VabFhtMDFXa1ZYZGY5UHZOeklVUVE?oc=5", "source_name": "Market source", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Biofrontera Inc. (BFRI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5BUFlSczREenlRQmlQenczZmZoNkVrc0FSbEIwckVocGVoYUoydjlVUkx6aUpJZHVfUTVJSFR6OUNDM0NFTnNldWJUX09EVnhVNWtONkZ6dEVSZDVFTnp1Uk9LRU5UUEU1VldRNnVtcmdWVERsQUVWcw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-09-15T17:50:41+00:00", "published_display": "15 Sep 2022 17:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Biofrontera Inc. (BFRI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE44SzY1cVExcXdSNVE5bmJBeENjV3lQcXNGeF96WGxra0J3T1QwX1pReTgyUHBzRHljM0tXd3VTWWhJOV85SVo5alpJQzhIUTc5MkdlbzhPY2JUYTF6ZUNjdnZpbVVHd0dKOW1wUw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2021-11-01T05:38:48+00:00", "published_display": "01 Nov 2021 05:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Stock Price, News & Analysis $BFRI", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE13NFZLMUw1LUVocmFILU4wNnlXVVVMMkQyX2ZyeTEwcThoRkI1bkFpbzg0VVJfdlM5STdkU0xfcXVrQ1ZMS25iWC13ekNjRmkwV1YzZDRFUUR5UQ?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-22T06:46:30+00:00", "published_display": "22 Oct 2021 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Liquidity Sweep", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWUtScWNPTWxLZE9zUnV5dS1US2g2QkhqMDVJb2ZuY1NBLVMwNDRFVy1ZMHZhV1JuUHFXeE9fRWZGaW1hVURhMHJVeDlJX1U1V3pURDdWODJ1TTBQUUJnWF9RcFNsa21XakhzV2E2cUkyS3o3SDh6RUxyN0F4WjV1VXBRUVFtaEVabjNyU29Oa1NsRnVaMmw5MzdWdVpHYjBqQTFLbWxteWZIQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-11T14:40:08+00:00", "published_display": "11 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Hagopian Line", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPRGlER1Y3cGZ2VmVnNGJjQzdodUloY0Y3YzA4RkQ4dGRJY0hHcHhheHlfNC1MeW4xWFRuUE8wejkydWVkZTQtZXdWcFFLSkNiSTNqSTk0QkQzeWpJU3YxUHJ4VEJJS0lFRldSeGVKWlY0NU9CbGFLY2N3RjAtUEVKUDZOWjRTUjR0Nk5HZWlVWU5sUm51OVNCNFZNcmtmc0JkSkhnbzhNV1pKR3NXRnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-11T14:30:21+00:00", "published_display": "11 Jul 2026 14:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article focuses on the enterprise value to EBIT forward of Biofrontera Inc., traded on NASDAQ under the ticker BFRI. It is primarily a data page from TradingView, indicating financial metrics for the pharmaceutical company. The content provided is minimal, serving mainly as ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T10:40:04", "published_display": "11 Jul 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frontier tech research, news & data", "summary": "The article provides a detailed growth snapshot of Biofrontera Inc. (BFRI), covering its revenue, net income, and EPS growth rates year-over-year. It presents both annual and quarterly growth data from FY2019 to Q1 FY26, highlighting the company's financial performance trends. Th", "url": "https://mlq.ai/companies/biofrontera-inc/growth/", "source_name": "MLQ.ai", "published_at": "2026-07-10T02:10:50", "published_display": "10 Jul 2026 02:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) AGM 2026 Summary", "summary": "Biofrontera (BFRI) held its 2026 Annual General Meeting, where directors and key executives participated remotely. The agenda included proposals for electing two Class II directors, amending the 2021 Omnibus Incentive Plan, and ratifying the independent auditor. The meeting summa", "url": "https://quartr.com/events/biofrontera-inc-bfri-agm-2026_F9UlMgni", "source_name": "Quartr", "published_at": "2026-07-08T12:10:47", "published_display": "08 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article displays information regarding Biofrontera Inc. (NASDAQ: BFRI)'s enterprise value to forward EBITDA. The information is presented within a TradingView interface, which provides financial data and tools for market analysis. The content is primarily a data placeholder ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T07:10:36", "published_display": "08 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Q4 2025 earnings summary", "summary": "Biofrontera (BFRI) reported record annual revenues of $41.7 million in 2025, a 12% increase year-over-year, with Q4 revenues reaching $17.1 million. The company achieved profitability in Q4 with a net income of $5.6 million and adjusted EBITDA of $4.9 million, driven by an asset ", "url": "https://quartr.com/events/biofrontera-inc-bfri-q4-2025_F9UlTSmi", "source_name": "Quartr", "published_at": "2026-07-08T06:11:12", "published_display": "08 Jul 2026 06:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Proxy filing Summary", "summary": "Biofrontera (BFRI) has released a summary of its proxy filing for the 2026 Annual Meeting scheduled for June 11, 2026. Key proposals include the election of two Class II directors, an increase in authorized shares for the 2021 Omnibus Incentive Plan, and the ratification of CBIZ ", "url": "https://quartr.com/events/biofrontera-inc-bfri-proxy-filing_F9UlMGEe", "source_name": "Quartr", "published_at": "2026-07-08T03:11:12", "published_display": "08 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-earnings forward metric. It appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analysis or numerical values fo", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T09:09:44", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI SEC Filings - Biofrontera Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Biofrontera Inc. (BFRI) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details recent filings from September 2025, highlighting insider beneficial ownership, convertible preferred stock conversions, an", "url": "https://www.stocktitan.net/sec-filings/BFRI/page-4.html", "source_name": "Stock Titan", "published_at": "2026-07-05T00:11:40", "published_display": "05 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI - Biofrontera Inc Options", "summary": "This article provides a detailed financial overview of Biofrontera Inc. (BFRI), including its stock performance, valuation metrics, earnings data, and insider/institutional ownership. It highlights the company's recent stock price of $1.16, a significant percentage change, and ke", "url": "https://finviz.com/stock?t=BFRI&p=d&ty=oc&b=1", "source_name": "Finviz", "published_at": "2026-07-04T11:40:35", "published_display": "04 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of Biofrontera Inc.'s financial disclosures and SEC filings, including earnings reports, quarterly and annual reports, and investor conference summaries dating back to 2021. It details key financial metrics, clinical pipeline progress, a", "url": "https://www.tradingview.com/symbols/BOATS-BFRIW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T07:40:07", "published_display": "02 Jul 2026 07:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-sales forward ratio. The content, sourced from TradingView, indicates that the market was closed at the time of publication and no trades were recorded. It offers an overvie", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T08:09:51", "published_display": "30 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Biofrontera Inc. \u2013 NASDAQ:BFRI", "summary": "This article provides a brief financial overview of Biofrontera Inc. (NASDAQ: BFRI), focusing on its price to book forward metric. It indicates that the market was closed at the time of publication and no trades were made. The content is primarily a financial data point without f", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T00:42:46", "published_display": "30 Jun 2026 00:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Biofrontera, Inc. \u2013 MUN:AI10", "summary": "The article title indicates a focus on the enterprise value to revenue forward ratio for Biofrontera, Inc. (MUN:AI10). The content found only contains this title and navigation information. No financial data or analysis is presented within the provided text.", "url": "https://www.tradingview.com/symbols/MUN-AI10/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T15:40:22", "published_display": "29 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A3EFRZ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Biofrontera, Inc. (A3EFRZ), including a 1-year price target of 5.11 EUR based on two analyst ratings. It also details recent financial performance, such as last quarter's earnings per share and revenue, and upcoming earnings report dates. The ", "url": "https://www.tradingview.com/symbols/LSX-A3EFRZ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T07:41:15", "published_display": "27 Jun 2026 07:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI10 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Biofrontera, Inc. (AI10) stock, based on analyst opinions, including maximum and minimum price estimates. It also details the company's financial performance, such as recent earnings and revenue, historical stock prices, and i", "url": "https://www.tradingview.com/symbols/MUN-AI10/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T02:10:20", "published_display": "27 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera, Inc. Actuals & Estimates (NASDAQ:BFRI)", "summary": "This article provides an overview of Biofrontera Inc. (NASDAQ: BFRI) stock, including its current price, historical performance, analyst forecasts, and financial data. It covers frequently asked questions regarding its stock ticker, price changes, market capitalization, earnings ", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T10:09:35", "published_display": "26 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BFRI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Biofrontera Inc. (BFRI) stock, incorporating analyst ratings, historical performance, and financial data. It addresses frequently asked questions about the stock's current price, volatility, market capitalization, earnings, an", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:42:46", "published_display": "26 Jun 2026 08:42", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Biofrontera Inc. \u2013 NASDAQ:BFRIW", "summary": "The article focuses on the \"Price to book forward\" financial metric for Biofrontera Inc. (NASDAQ: BFRIW). It appears to be a stub or a data point from a financial platform like TradingView, showing the value and change of this specific metric for the company. The content itself p", "url": "https://www.tradingview.com/symbols/NASDAQ-BFRIW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T04:41:50", "published_display": "26 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Biofrontera Inc (BFRI) has a weak financial status but high operating efficiency, with a current financial score of 7.82, ranking 98 out of 157 in the Pharmaceuticals industry. The company recently reported a 17.42% year-over-year increase in quarterly revenue to $10.08M and a 13", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T18:40:20", "published_display": "23 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Shows Modest Bounce Near Key Support Level - Entry Point Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRW5TOTlaTVVYeGRaR2NwazgybzlUdGVkdk4xdjc1QW1NNjdlQVJBVW1IUmdXRjZYOWZaWFB4UTlsMzRJa2xJZndSUVhTSGJmVjkyNTMxcnNGaFNSdlVFeFlYTGpDS1NSeHVlRFZxWjNPdW00MG8xdlZ1b1NacUI0VW5OdDNycVpPWnM3NndWUTEwZG9GeEtMRWJUc2tBT2QyWmpVZ2lhOXdEY3h1SDI4?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc.'s (NASDAQ:BFRI) Path To Profitability", "summary": "Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company, is projected by analysts to reach profitability in 2027, with an anticipated breakeven point just over a year from the article's publication. This forecast relies on an optimistic annual growth rate of 63%. The company,", "url": "https://www.sahmcapital.com/news/content/biofrontera-incs-nasdaqbfri-path-to-profitability-2026-06-20", "source_name": "Sahm", "published_at": "2026-06-20T17:11:42", "published_display": "20 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Institutional Confidence", "summary": "This article from TradingKey provides an overview of Biofrontera Inc's (BFRI) institutional confidence score and shareholder activity as of June 18, 2026. It lists key institutional shareholders, the number of shares they hold, and the percentage change in their holdings. The com", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T04:10:40", "published_display": "19 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRIW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "The article provides a detailed breakdown of Biofrontera Inc's (BFRIW) shareholder structure, including categories of shareholders and institutional holdings over several recent quarters. It lists major institutional investors and their changes in shareholding, offering insights ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfriw/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T07:46:52", "published_display": "18 Jun 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Valuation: PE, PB & Fair Value Analysis", "summary": "Biofrontera Inc (BFRI) currently has a valuation score of 9.06, placing it 54th out of 157 in the Pharmaceuticals industry. Its P/E ratio stands at -1.01, which is significantly below its recent high but above its recent low. The company has not yet disclosed relevant data for P/", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T07:39:46", "published_display": "18 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "The article provides a historical overview of Biofrontera Inc's (BFRI) dividend distributions and stock split events. It notes that the company has not distributed any dividends in the past five years. However, it details multiple 20-for-1 merger-related stock splits that occurre", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:46", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Biofrontera Inc (BFRI), listing major shareholders and their proportions, including Rosalind Advisors, Inc. and AIGH Capital Management, LLC. It also breaks down shareholder types such as hedge funds and individual investors. Addi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:00", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Biofrontera Inc. (BFRI), detailing its segment and regional revenue contributions. However, it notes that relevant data for fiscal years 2021-2025 has not yet been disclosed by the company. The only specific financial detail provided ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfri/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:00", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (NASDAQ: BFRI) OKs directors, bigger incentive plan and auditor", "summary": "Biofrontera Inc. (BFRI) held its Annual Meeting of Stockholders on June 11, 2026, where shareholders approved several key proposals. They elected Beth J. Hoffman and Kevin D. Weber as Class II directors, significantly increased the authorized shares for the 2021 Omnibus Incentive", "url": "https://www.stocktitan.net/sec-filings/BFRI/8-k-biofrontera-inc-reports-material-event-751fbb62d041.html", "source_name": "Stock Titan", "published_at": "2026-06-17T19:39:00", "published_display": "17 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRIW) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Biofrontera Inc (BFRIW), including its stock price, market capitalization, and P/E TTM. It lists various institutional shareholders and their recent activity, such as shares held and changes in holdings. The data in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bfriw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T08:11:34", "published_display": "17 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/e5890ce7-945e-34fe-a70a-c76ac3ac8384/biofrontera-%28bfri%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T17:16:02+00:00", "published_display": "02 Jun 2026 17:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Edges Higher: A Small-Cap Biotech Finds Temporary Footing - Low Volume Node", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOYWxiT0Y3a1BvM2tjaE1hcHdrLW1RLXFfTzZ6VzlLVWZONjU5cVQ4bGZYcXV2VGs1X01VMzlIQ2ZSSFpXT284Yk5sam1NOFllZjVXM3E5YWNVUEFWczVVLUFnU1owVHNwZzh4RE1wM0dXTzdFM3pSb0RnWkFneG5CZzNqVF80aXhYQ0NuWmtjbGxaNXBqX0VhMVZZbXhENlZMRGZrcklJMFdjYzAyTEk4dDRCZnVhano3RTUydmJHNjk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-participate-lytham-partners-131500277.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T13:15:00+00:00", "published_display": "21 May 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-bfri-q1-2026-230428053.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T23:04:28+00:00", "published_display": "14 May 2026 23:04", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-reports-first-quarter-113000573.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T11:30:00+00:00", "published_display": "14 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSXdpZV94UXMtWFp1alp5WVA0eXdEMklsdHFZdWNiNGVLUzJIZy1XNE9YS2ZHUG1obFZxd2IxaGZfQWEwXy1NSWlPREZmeXdYQlF4R0hGT3I1SlFacjhmdEU5c3k2dnc2S1ZBazhSc3F5ZHFkSzU0dlBRVHU4NENHWGlMb2dZTDhoR2tZajJ3Z05rNzdPSHNxNUM0elo?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BIOFRONTERA ($BFRI) Releases Q1 2026 Earnings | BFRI Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQSEJBSVVIZFpOOEV6MXJESm5EbTUyTkVZVWQxZFpfak1OSE5VMzA2bnRaaE9MQmsxbEtsTjZRSzRxMGRzTGZ5UkNzU0V5YnhiOG1Ub3NDd0d3LUtlX3BCWG5VUkpXNk9vN2Z1bVp1WU9lc3Y4cEZVdHdXSkR4OXpCckhhR1QxMXdPRDlKWg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Launches Second Annual \u201cHats On\u201d Campaign to Raise Awareness of Actinic Keratosis", "summary": "", "url": "https://finance.yahoo.com/news/biofrontera-launches-second-annual-hats-130000565.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T13:00:00+00:00", "published_display": "13 May 2026 13:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biofrontera-inc-report-first-quarter-200000977.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T20:00:00+00:00", "published_display": "08 May 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVmR0bmpFcjZtWWY5WG8tS2dUa3JxTzZuZXVQMWJUeUlDTDAwRWNibm1KQjd4aWMzbGxjVml1OFNXek1KenQ0eVZ4TkxqUXE5UkJHVnhnLTY2Y3gxeWR4UlZBQWhmMmo3czBkdmpaS0lYbEQ5UmY0aS11cjBQRWdWS3VabFhtMDFXa1ZYZGY5UHZOeklVUVE?oc=5", "source_name": "Market source", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Biofrontera Inc. (BFRI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5BUFlSczREenlRQmlQenczZmZoNkVrc0FSbEIwckVocGVoYUoydjlVUkx6aUpJZHVfUTVJSFR6OUNDM0NFTnNldWJUX09EVnhVNWtONkZ6dEVSZDVFTnp1Uk9LRU5UUEU1VldRNnVtcmdWVERsQUVWcw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-09-15T17:50:41+00:00", "published_display": "15 Sep 2022 17:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Biofrontera Inc. (BFRI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE44SzY1cVExcXdSNVE5bmJBeENjV3lQcXNGeF96WGxra0J3T1QwX1pReTgyUHBzRHljM0tXd3VTWWhJOV85SVo5alpJQzhIUTc5MkdlbzhPY2JUYTF6ZUNjdnZpbVVHd0dKOW1wUw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2021-11-01T05:38:48+00:00", "published_display": "01 Nov 2021 05:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biofrontera (BFRI) Stock Price, News & Analysis $BFRI", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE13NFZLMUw1LUVocmFILU4wNnlXVVVMMkQyX2ZyeTEwcThoRkI1bkFpbzg0VVJfdlM5STdkU0xfcXVrQ1ZMS25iWC13ekNjRmkwV1YzZDRFUUR5UQ?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-22T06:46:30+00:00", "published_display": "22 Oct 2021 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 45, "sentiment_summary": {"positive": 10, "negative": 1, "neutral": 34, "score": 53, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 13.0, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 9.35, "count": 17}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1.1, "latest_week": "2026-07-10", "one_week_move": 8.9, "four_week_move": 27.2, "twelve_week_move": 0.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.222798, "market_dynamics_buy_signal": false, "relative_strength": 2.195129, "fair_value_gap": -42.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.1137, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+8.9% over one week, +27.2% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 12}, {"label": "TradingKey", "count": 8}, {"label": "GlobeNewswire", "count": 4}, {"label": "Quartr", "count": 3}, {"label": "dars.gov.et", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "Donan\u0131mHaber", "count": 2}, {"label": "Market source", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 17}, {"label": "Guidance", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+8.9% over one week, +27.2% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Liquidity Sweep"}], "updated_at": "2026-07-16T06:04:51.110801+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}